Craft
Almac Group

Almac Group

Revenue

£735.1 M

FY, 2021

Total Funding

$1 M

Almac Group Summary

Company summary

Overview
Almac Discovery is a research company engaged in the development of therapeutic drugs. It offers clients solutions within three core service lines: Genomic Services, Clinical Trial Assays, and Companion Diagnostics. The company specializes in biomarker discovery, development and commercialization, active pharmaceutical ingredient (API) manufacturing, formulation development, clinical trial supply, commercial scale manufacturing, etc.
Type
Private
Status
Active
Founded
1968
HQ
Craigavon, GB | view all locations
Website
https://www.almacgroup.com/
Cybersecurity rating
Sectors

Key people

  • Paul Harkin

    Paul Harkin, President and Managing Director

    • Alan Armstrong

      Alan Armstrong, Chairman & CEO

      • Michael Sloan

        Michael Sloan, Global VP of Commercial Operations

        • Colin Hayburn

          Colin Hayburn, Executive Director

          LocationsView all

          15 locations detected

          • Craigavon, Northern Ireland HQ

            United Kingdom

            Almac House, 20 Seagoe Rd

          • Audubon, PA

            United States

            2661 Audubon Rd

          • Durham, NC

            United States

            4238 Technology Dr

          • Lansdale, PA

            United States

            1690 Sumneytown Pike

          • San Francisco, CA

            United States

            180 Montgomery St #1500, San Francisco

          • Souderton, PA

            United States

            25 Fretz Rd

          and 9 others

          Almac Group Financials

          Summary financials

          Revenue (FY, 2021)
          £735.1M
          Gross profit (FY, 2021)
          £260.3M
          Net income (FY, 2021)
          £64.2M
          Cash (FY, 2021)
          £115.1M
          EBIT (FY, 2021)
          £90.1M

          Footer menu